Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
International Journal of Urology : Official Journal of the Japanese Urological Association|March 13, 2024
Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in JapanYosuke Yasuda, Noboru Numao, Ryo Fujiwara, et al.Journal of General and Family Medicine|June 8, 2026
Barriers and Associated Factors to Writing Case Reports Among Japanese General Medicine Physicians: A Cross-Sectional Study of the Japan Primary Care Association MembersTsuneaki Kenzaka, Shinsuke Yahata, Naoya Mizutani, et al.Hinyokika Kiyo. Acta Urologica Japonica|October 21, 2016
[A Case of Synchronous Multiple Metastases in which the Origin Could Not Be Identified by Routine Examination]Ryo Fujiwara, Mitsuhiro Narita, Susumu Kageyama, et al.Anticancer Research|March 29, 2022
Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted TherapyMotohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, et al.Cancers|August 10, 2024
Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors TherapyRyo Fujiwara, Shinya Yamamoto, Kosuke Takemura, et al.Clinical Genitourinary Cancer|December 6, 2020
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With NivolumabRyo Fujiwara, Kosuke Takemura, Motohiro Fujiwara, et al.Anticancer Research|March 29, 2022
Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial CancerMotohiro Fujiwara, Ryo Fujiwara, Tetsuya Urasaki, et al.Cancer Diagnosis & Prognosis|September 6, 2024
Predictors of Progression to Castration-resistant Prostate Cancer After Radical Prostatectomy in High-risk Prostate Cancer PatientsTakato Nishino, Shinya Yamamoto, Noboru Numao, et al.Cancer Chemotherapy and Pharmacology|June 10, 2021
Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancerMotohiro Fujiwara, Takeshi Yuasa, Shotaro Yasuoka, et al.International Journal of Clinical Oncology|September 16, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancerRyo Fujiwara, Kentaro Inamura, Takeshi Yuasa, et al.Pageof 6